Views

WHITE PAPER – Are there only 10 commercial strategies in pharma?

WHITE PAPER – Are there only 10 commercial  strategies in pharma?

It goes without saying that strategic planning is an important determinant of the success of any asset, brand or portfolio. Done well it can set direction, shape performance, provide focus for the organisation and enable thoughtful allocation of resources. But add in the reality of project management, team alignment, coordination across geographies, review meetings, slide development, rehearsals and often the sheer length of the process, and it can sometimes start to feel like an obstacle to implementation or getting on with the day job.
It’s useful to remind ourselves however, that on one level strategy isn’t that complex, or at least there aren’t that many options. I’m going to argue that there are 10 commercial strategies in pharma. I invite readers to dispute this. Whatever the final number I suspect it will be finite and manageable…

Complete the information below to download your free copy of the White Paper

For further information about our range of services

Contact Us

Share this

Related Articles

Happy MedComms Day 2021
08 June 2021
Happy MedComms Day 2021

Happy MedComms Day 2021 from Cello Health’s Global Communications Team

WHITE PAPER – Biotech and Breakthroughs in Immuno-Oncology
19 January 2021
WHITE PAPER – Biotech and Breakthroughs in Immuno-Oncology

White paper by Jeffrey M. Bockman, PhD. Biotech and Breakthroughs in Immuno-Oncology

EVENT – Cancer Progress, Virtual | May 4-6 2021
19 January 2021
EVENT – Cancer Progress, Virtual | May 4-6 2021

Join us at Cancer Progress, Virtual May 4-6 2021 ❝ Inspiring Cancer Progress through engaged stakeholder dialogue ❞

WHITE PAPER – Early Asset Commercialization Strategy: The Time is Now
19 January 2021
WHITE PAPER – Early Asset Commercialization Strategy: The Time is Now

The biotech industry is in an exciting period of growth and innovation, the number of new products being registered continues to increase year on year, with a significant proportion of these being novel, first in class medicines.

Let’s work together

The journey to scientific and commercial success is often complex and always critical, if you are looking for an expert partner to help steer you to confident solutions, contact us today

Contact us